Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD20222023
Revenues<1m<1m
  • Edit
DateInvestorsAmountRound
*

N/A

Seed
N/A

$4.0m

Seed

$500k

Grant
*

SGD1.4m

Early VC
Total Funding€5.0m

Recent News about Insectta

Edit
More about Insecttainfo icon
Edit

Insectta is a pioneering company that specializes in extracting high-value biomaterials from the black soldier fly using proprietary technology. Operating in the sustainable biomaterials market, Insectta serves a diverse range of clients across various industries, including healthcare, cosmetics, and organic electronics. The company’s business model revolves around the commercial sale of these biomaterials, such as chitosan and melanin, which are exported from Singapore to research facilities and manufacturers worldwide. Chitosan, a natural biopolymer, is favored for its non-toxicity, low allergenicity, biocompatibility, and biodegradability, making it an excellent alternative to synthetic materials. Melanin, another key product, is 100% water-soluble and has significant potential in biomedicine and supercapacitors. By leveraging cutting-edge technology and nature, Insectta aims to contribute to a circular economy and promote sustainability.

Keywords: biomaterials, black soldier fly, chitosan, melanin, sustainability, healthcare, cosmetics, organic electronics, biocompatibility, biodegradability.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.